Islandsbanki hf.
Íslandsbanki hf. has today issued the following bond under its Global Medium Term Notes (GMTN) Programme with the following terms:
Issuer: Íslandsbanki hf.
Issue Size: NOK 150,000,000
Value date: 26 March 2021
Maturity Date: 26 March 2024
Listing: Irish Stock Exchange
ISIN: TBC
Dealer: SEB
Issuer: Íslandsbanki hf.
Issue Size: NOK 750,000,000
Value date: 26 March 2021
Maturity Date: 26 March 2025
Listing: Irish Stock Exchange
ISIN: TBC
Dealers: Nordea, Swedbank
Issuer: Íslandsbanki hf.
Issue Size: SEK 250,000,000
Value date: 26 March 2021
Maturity Date: 26 March 2024
Listing: Irish Stock Exchange
ISIN: TBC
Dealers: Danske Bank
Issuer: Íslandsbanki hf.
Issue Size: SEK 450,000,000
Value date: 26 March 2021
Maturity Date: 26 March 2025
Listing: Irish Stock Exchange
ISIN: TBC
Dealers: SEB, Swedbank
Information on Íslandsbanki’s USD 2,500,000,000 GMTN and its supplements are available here.
For further information: ir@islandsbanki.is
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Sequana Medical NV9.7.2025 18:00:00 CEST | Press release
Press release: Transparency Notification from Shareholders
Siili Solutions Oyj9.7.2025 17:30:00 CEST | Press release
Siili Solutions Plc: Share Repurchase 9.7.2025
TCM Group A/S9.7.2025 17:05:00 CEST | Pressemeddelelse
TCM Group A/S: Storaktionærmeddelelse
TCM Group A/S9.7.2025 17:05:00 CEST | Press release
TCM Group A/S: Major shareholder announcement
Bavarian Nordic A/S9.7.2025 16:46:37 CEST | Pressemeddelelse
Bavarian Nordic modtager ny ordre på koppe-/mpoxvacciner fra europæisk land
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom